Cent Eur J Public Health 2007, 15(2):84-86 | DOI: 10.21101/cejph.a3405

Low-threshold Services for Problem Drug Users in Hungary

Katalin Melles1, Ferenc Márványkövi1, Jozsef Rácz1,2
1 Research Institute on Drug Studies, Eötvös University, Budapest
2 Institute for Psychology, Hungarian Academy of Sciences, Budapest

Objectives: The main objective of this study was to explore how harm reduction (HR) approach and low-threshold approach are realised at low-threshold services (LTSs) in Hungary in comparison with the guidelines presented in different policy papers (European Union drugs strategies) and national regulations.

Materials and methods: Hungarian LTSs were investigated: 29 organisations out of 44 (66% return rate) were reached with questionnaires and 40 LTS workers were interviewed.

Results: The LTSs have difficulties reaching their target group, distributing sufficient sterile syringes and interpreting the concept of 'low-threshold' and HR, sometimes defining them as a transient stage to abstinence-based treatment.

Conclusion: The study results suggest that Hungarian LTSs need to be re-orientated toward more emphasis on health-related issues.

Klíčová slova: drug abuse, harm reduction, Hungary, low-threshold service

Vloženo: 2. srpen 2006; Revidováno: 13. únor 2007; Přijato: 13. únor 2007; Zveřejněno: 1. červen 2007  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Melles K, Márványkövi F, Rácz J. Low-threshold Services for Problem Drug Users in Hungary. Cent Eur J Public Health. 2007;15(2):84-86. doi: 10.21101/cejph.a3405. PubMed PMID: 17645224.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. Burrows D, editor. High coverage sites: HIV prevention among injecting drug users in transitional and developing countries: case studies. Geneva: UNAIDS; 2006.
    2. European Union drugs strategy (2000-2004). 12555/3/99 REV 3, Cordrogue 64. Brussels: Council of the European Union; 1999.
    3. National drug strategy for the reduction of drug problems. Budapest: Ministry of Youth and Sports Affairs; 2000. (In Hungarian.)
    4. Hedrich D. Data-collection at low-threshold services for drug users: tools, quality and coverage. Lisbon, 9-10 December 2004, EMCDDA [final draft meeting report]. Luxembourg: Office for Official Publications of the European Communities; 2004.
    5. Marlatt AG, editor. Harm reduction: pragmatic strategies for managing high-risk behaviors. New York: The Guilford Press; 1998.
    6. Reid RJ. Harm reduction and injection drug use: pragmatic lessons from a public health model. Health Soc Work. 2002 Aug,27(3):223-6. Přejít k původnímu zdroji...
    7. Donoghoe MC, Lazarus JV, Matic S. HIV/AIDS in the transitional countries of Eastern Europe and Central Asia. Clin Med. 2005 SepOct;5(5):487-90. Přejít k původnímu zdroji...
    8. European Monitoring Centre for Drugs and DrugAddiction (EMCDDA). The state of the drugs problem in the acceding and candidate countries to the European Union. Luxembourg: Office for Official Publications of the European Communities; 2003.
    9. Kraus L, Augustin R, Frischer M, Kümmler P, Uhl A, Wiessing L. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction. 2003 Apr;98(4):471-85. Přejít k původnímu zdroji...
    10. Smit F, Toet J, van Oers H, Wiessing L. Estimating local and national problem drug use prevalence from demographics. Addict Res Theory. 2003 Dec;11(6):401-13. Přejít k původnímu zdroji...
    11. European Monitoring Centre for Drugs and DrugAddiction (EMCDDA). Annual Report 2003: the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities; 2003.
    12. European Monitoring Centre for Drugs and DrugAddiction (EMCDDA). Annual Report 2005: the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities; 2005.
    13. Hibell B, Andersson B, Bjarnason T, et al. The ESPAD Report 2003: alcohol and other drug use among students in 35 European Countries. Strasbourg: The Swedish Council for Information on Alcohol and Other Drugs (CAN) and Council of Europe Pompidou Group; 2004.
    14. European Centre for the Epidemiological Monitoring ofAIDS. HIV/AIDS Surveillance in Europe. End-year report 2004, No.71. Saint Maurice: Institut de Veille Sanitaire; 2005.
    15. Bánhegyi D, Ujhelyi E, Zacher G. The infection risk of injecting drug use. In: Topolánszky Á, editor. Hungarian national report on drug use. Budapest: GYISM; 2002. p. 81-8. (In Hungarian.)
    16. Social Law (No. 3/1993 modification is in operation from January 1 2007). (In Hungarian.)
    17. Hungarian Civil Liberties Union [homepage on the Internet]. HCLU about harm reduction oriented drug policy. Budapest: TASZ; 1998. [cited 2006 Aug 2].Available from: http://www.tasz.hu/index.php?op=contentlist2&catalog_id=1625
    18. Kály-Kullai K, editor. Collection of drug services. Budapest: "Island" Drug Information Foundation; 2003. (In Hungarian.)
    19. Nyírády A, Porkoláb L. Problem drug use. In: Nyírádi A, Felvinczi K, Gábor E, editors. Hungarian national report on drug use. Budapest: Ministry of Youth, Family Affairs and Equal Opportunities; 2004. p. 53-61. (In Hungarian.)
    20. Elekes Zs, NyírádiA. Estimating the prevalence of problem drug use with the capture-recapture method. Addiktológia (Addictologia Hungarica). In press 2007. (In Hungarian.)
    21. National Statistical Programme. National report on drug situation in Hungary. Budapest: National Institute for Psychiatry and Neurology; 2004. (In Hungarian.)
    22. European Monitoring Centre for Drugs and DrugAddiction (EMCDDA). National prevalence estimates of problem drug use in the European Union, 1995-2000. Final Report CT.00.RTX.23 - Data update for EMCDDA 2003 Annual Report. Lisbon: EMCDDA; 2003.
    23. Csohán Á, Kaszás K, Lendvai Gy. Prevalence of infectious diseases among injecting drug users [unpublished research report]. Budapest: National Centre of Epidemiology; 2006. (In Hungarian.)
    24. Gyarmathy VA, Rácz J, Neaigus A, Ujhelyi E. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary. AIDS Educ Prev. 2004 Jun;16(3):276-87. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah